Clinical Trials Browser

INDUSTRY × Fallopian Tube Neoplasms × conatumumab × Clear all

NCT01940172 2016-01-14

Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer

Phase 1 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms